MRD As the New Standard for Outcomes Measurement in CLL

This animated tool describes the disease of chronic lymphocytic leukemia (CLL) and outlines the importance of minimal residual disease in the treatment of CLL.

MRD As the New Standard for Outcomes Measurement in CLL